🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754
This clinical trial will study the use of ridaforolimus in metastatic breas...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00736970
Treatments Being Tested
This phase I trial studies the side effects and best dose of nanoparticle a...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-08-15
Trial ID
NCT02975882
The purpose of this study is to test the safety, tolerability, and efficacy...
Status
Completed
Location
Multiple Locations
Start Date
2009-03-27
Trial ID
NCT00704405
Treatments Being Tested
This study assessed the safety and efficacy of MK-3577. The primary efficac...
Status
Terminated
Location
Multiple Locations
Start Date
2009-03-24
Trial ID
NCT00868790
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK) profile ...
Status
Completed
Location
Call for Information (Investigational Site 0003)
Start Date
2013-03-06
Trial ID
NCT01797536
Treatments Being Tested
The purpose of this study is to assess the effect on various biomarkers of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11-27
Trial ID
NCT01852825
This is a 2-part study in participants with renal impairment and matched he...
Status
Completed
Location
Multiple Locations
Start Date
2011-08-08
Trial ID
NCT01407276
Treatments Being Tested
This study will evaluate MK0457 in combination with Dasatinib in patients w...
Status
Terminated
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00500006
This study will be conducted in subjects with established Parkinson's disea...
Status
Completed
Location
Centre for Human Drug Research
Start Date
2019-10-16
Trial ID
NCT04157933